₹367.48
+₹43.10 (+13.29%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹3,198 Cr
P/E
55.80
ROE
3.57%
ROCE
4.36%
About Ind-Swift Laboratories Ltd
Ind-Swift Laboratories as an API manufacturer the Company has shifted its focus to formulation as its key business driver.
Founded
1995
CEO
N R Munjal
Employees
1,246
HQ
Chandigarh, India
About Ind-Swift Laboratories Ltd
Ind-Swift Laboratories as an API manufacturer the Company has shifted its focus to formulation as its key business driver.
Founded:1995
CEO:N R Munjal
Employees:1,246
HQ:Chandigarh, India
Finished Products
1Sale of Manufacturing Goods
₹2,190.31Cr2Sale of Services
₹31.91CrRaw Materials
1Raw Materials Consumed
₹936.40Cr2Purchases
₹140.97CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹374
52W Low
₹87
Volume7.37M
Avg VolumeN/A
Beta0.86
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
55.80x
Valuation
P/B Ratio
2.31x
Valuation
EPS
₹6.59
Valuation
Dividend Yield
0.00%
Valuation
ROE
3.57%
Profitability
ROCE
4.36%
Profitability
Revenue by Segment
Contribution & growth by business line
Bulk Drugs & PharmaceuticalsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
27.7%
International
72.3%
Outside India72.3%
In India27.7%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.01x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-22.5%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.